riSk Factors fOR neCk phlEgmon afteR pErcutaneous tRacheostomy in ICU
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorAzienda Usl di Bologna
About this trial
Primary Purpose: To investigate the incidence and risk factors related to the appearance of tracheal phlegmon in patients undergoing percutaneous tracheostomy.
Participant Population/Primary Condition: Patients admitted to Intensive Care
Main Questions Aims to Answer:
1. \- What are the risk factors associated with the development of tracheal phlegmon percutaneous tracheostomy? 2. \- How does the appearance of tracheal phlegmon impact intensive care stay, hospital stay, mortality, and Health-related quality of life?
Participants will be followed up after undergoing tracheostomy for 7 days to identify eventual phlegmons.
At the two-year follow-up, the health-related quality of life will be assessed
Eligibility criteria
Qualifiers
Age greater than 18 years
Presence of indication for tracheostomy
Disqualifiers
Failure of the percutaneous tracheostomy technique or recourse to surgical tracheostomy
Trial design
Treatments tested in this trial
- Percutaneous tracheostomy
Treatment groups
300 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov